Physostigmine: Difference between revisions
No edit summary Tag: mobile edit |
|||
| Line 1: | Line 1: | ||
==General== | ==General== | ||
*Type: | *Type: acetylcholinesterase inhibitor | ||
*Dosage Forms: | *Dosage Forms: | ||
*Common Trade Names: | *Common Trade Names: | ||
==Adult Dosing== | ==Adult Dosing== | ||
Revision as of 20:55, 30 December 2015
General
- Type: acetylcholinesterase inhibitor
- Dosage Forms:
- Common Trade Names:
Adult Dosing
Anticholinergic toxicity
- 0.5-2mg IV over 5min
Pediatric Dosing
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
- Side effects: bradycardia, dysrhythmias, cholinergic excess
- Always have atropine at the bedside for bradycardia or cholinergic excess
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
- Onset of action: 15-20min